SANA BIOTECHNOLOGY INC. - COMMON STOCK

Sana Biotechnology Congratulates Senior Vice President and Head of T Cell Therapeutics, Terry Fry, M.D., on Additional Role at the University of Colorado’s Gates Institute

12 مايو 2022 17:40:02 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Reports First Quarter 2022 Financial Results and Business Updates

10 مايو 2022 16:05:01 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present at the BofA Securities 2022 Healthcare Conference

04 مايو 2022 16:05:01 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present Data from Multiple Preclinical Studies at the American Society of Gene and Cell Therapy 25th Annual Meeting

02 مايو 2022 16:35:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates

16 مارس 2022 08:30:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present at the 32nd Annual Oppenheimer Healthcare Conference

09 مارس 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present Preclinical Data on its Engineered Hypoimmune Allogeneic CAR T Cells at the 2022 American Association for Cancer Research Annual Meeting

08 مارس 2022 16:35:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Obtains Exclusive License from National Institutes of Health for CD22 CAR Construct

11 يناير 2022 06:00:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct

10 يناير 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present at the 40th Annual J.P. Morgan Healthcare Conference

04 يناير 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Presentations at 2021 ASH Annual Meeting Highlight Progress with Platforms and CAR T Cell Programs

12 ديسمبر 2021 09:05:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Reports Third Quarter 2021 Financial Results and Business Updates

08 نوفمبر 2021 16:05:02 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present Pre-Clinical Data at 2021 American Society of Hematology Annual Meeting

04 نوفمبر 2021 09:07:03 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Obtains a Non-Exclusive License to CRISPR Cas12b Gene Editing Technology from Beam Therapeutics to Enable Engineered Cell Programs

19 أكتوبر 2021 09:00:01 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

07 سبتمبر 2021 16:05:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Reports Second Quarter 2021 Financial Results and Business Updates

04 أغسطس 2021 16:05:04 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Enters Long-Term Lease to Establish Manufacturing Facility to Enable Its Gene and Cell Therapy Product Candidates

14 يوليو 2021 16:10:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Presents Data at ISSCR 2021 Virtual Annual Meeting Showing Survival of Transplanted Hypoimmune Stem Cells Without Immunosuppression in Non-Human Primates

26 يونيو 2021 10:42:38 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present During Plenary Sessions at ISSCR 2021 Virtual Annual Meeting

14 يونيو 2021 09:15:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

02 يونيو 2021 16:05:00 بحسب Nasdaq GlobeNewswire